1072TiP Phase I/II dose escalation/expansion trial to evaluate safety and preliminary efficacy of DuoBody-EpCAM×4-1BB (BNT314/GEN1059) alone or in combination with an immune checkpoint inhibitor in patients with malignant solid tumors.
Saved in:
| Title: | 1072TiP Phase I/II dose escalation/expansion trial to evaluate safety and preliminary efficacy of DuoBody-EpCAM×4-1BB (BNT314/GEN1059) alone or in combination with an immune checkpoint inhibitor in patients with malignant solid tumors. |
|---|---|
| Authors: | Melero, I.1 (AUTHOR), Lakhani, N.J.2 (AUTHOR), Powderly, J.3 (AUTHOR), Adjei, A.A.4 (AUTHOR), Lopez, J.S.5 (AUTHOR), Paz-Ares, L.G.6 (AUTHOR), Moreno Candilejo, I.7 (AUTHOR), Thistlethwaite, F.8 (AUTHOR), Rohrberg, K.S.9 (AUTHOR), Jerusalem, G.10 (AUTHOR), Malmberg, A.11 (AUTHOR), Ioan-Facsinay, A.12 (AUTHOR), Upadhyay, P.J.13 (AUTHOR), Tan, B.14 (AUTHOR), Bartz, R.15 (AUTHOR), Gaziel, T.B.B.16 (AUTHOR), Forssmann, U.16 (AUTHOR), Celik, I.17 (AUTHOR), Gann, C.18 (AUTHOR), De Mattos-Arruda, L.17 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS709-S710. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.08.1130 |
